干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
干细胞之家 - 中国干细胞行业门户第一站 干细胞之家论坛 干细胞行业新闻 Improved Method to Create Induced Pluripotent Stem C ...
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 19788|回复: 3
go

Improved Method to Create Induced Pluripotent Stem Cells [复制链接]

Rank: 4

积分
2555 
威望
2555  
包包
600  

优秀会员

楼主
发表于 2011-7-24 11:41 |只看该作者 |倒序浏览 |打印
    University of Minnesota Medical School researchers have developed a new strategy to improve the development of induced pluripotent stem cells (iPS). Currently, iPS cells are created by introducing four defined genes to an adult cell. The genes reprogram the adult cell into a stem cell, which can differentiate into many different types of the cells in the body. Typically, the four genes introduced are Oct4, Sox2, Klf4 and c-Myc, a combination known as OSKM.3 c& U( W& U5 x8 P/ ]& `. c+ ^6 h2 g( ?
    The U of M researchers found that by fusing two proteins -- a master stem cell regulator (Oct4) and a fragment of a muscle cell inducer (MyoD) -- they succeeded in "powering up" the stem cell regulator, which can dramatically improve the efficiency and purity of reprogrammed iPS cells.  M) M3 y/ d4 B$ T  N+ h
    "Our team discovered that by fusing a fragment of the powerful protein MyoD to Oct4 we could create a 'super gene' which would improve the iPS reprogramming process," said senior author Dr. Nobuaki Kikyo, Stem Cell Institute researcher and University of Minnesota Medical School associate professor. "The result is what we termed M3O, or 'super Oct4' -- a gene that improves the creation of iPS cells in a number of ways. In the process we shed new light on the mechanism of making iPS cells."
  B, m6 d0 c8 ?' o3 b- w3 }    The challenge with the previous method -- OSKM -- has been that very few cells actually become iPS cells during reprogramming. In fact, the rates currently stand at about 0.1 percent. Another issue has been tumor development. Because some of the reprogramming genes introduced are oncogenes, the risk of developing tumors grows.
5 u8 s! g2 ^  }$ eThe research, led by Kikyo and Dr. Hiroyuki Hirai, both from University of Minnesota Medical School and Stem Cell Institute, led to a new gene model that minimizes such complications while amplifying the benefits of the process.
7 V3 }* ^- k( T& T. f+ |    According to Kikyo, the new gene model -- called M3O-SKM -- improves iPS development by:
3 e' k: |5 c& `4 k9 }; M) @( S    Increasing efficiency. The efficiency of making mouse and human iPS cells was increased over 50-fold compared with the standard OSKM combination. Increasing purity. The purity of the iPS cells was much higher with the M3O-SKM gene introduction (98% of the colonies) compared with OSKM (5%). Facilitating the reprogramming. iPS cell colonies appeared in around five days with M3O-SKM, in contrast to around two weeks with OSKM. Decreasing the potential for tumor formation. M3O achieved high efficiency of making iPS cells without c-Myc, an oncogene that can potentially lead to tumor formation.
& Y- c- a( a! k2 y( n    In addition, human iPS cells usually require co-culture with feeder cells typically prepared from mouse cells, obviously creating a problem when the cells are destined for human transplantation. The M3O model did not require such feeder cells, greatly simplifying the process.
3 {4 A4 ^5 x# `$ E6 V' A/ ^The new process is outlined in the latest issue of the journal Stem Cells.
  D* g6 A1 ^) _3 `Future Impact    ' Z5 S# g* O0 I! i& @7 |
    According to senior author Kikyo, this new strategy will dramatically speed up the process of making patient-specific iPS cells, which makes clinical applications via transplantation of the cells more feasible to treat many diseases incurable otherwise.
4 x. K! @, \" a6 r3 x    Many researchers are also examining how to reprogram one cell type into another without going through iPS cells; for instance, coaxing skin cells into becoming neurons or pancreas cells by introducing several genes.
" d5 W% S" F* E/ O6 A4 S" g    The approach, called direct reprogramming, is thought to be the next generation approach beyond iPS cell technology.3 c! N; d2 J. n; a
The U of M approach -- fusing a powerful protein fragment to other host proteins -- can be widely applied to the direct reprogramming approach as well.& I" I; [) V" J
    This research was funded by the Richard M. Schulze Family Foundation, NIH, Leukemia Research Fund and Academic Health Center of the University of Minnesota.
已有 1 人评分威望 包包 收起 理由
yangpan521 + 2 + 5 欢迎讨论

总评分: 威望 + 2  包包 + 5   查看全部评分

Rank: 3Rank: 3

积分
559 
威望
559  
包包
1201  

优秀会员 金话筒

沙发
发表于 2011-7-24 15:09 |只看该作者
本帖最后由 托斯卡纳教父 于 2011-7-24 15:09 编辑
: U, n8 {5 ?" _* i8 {  F3 E' C/ p1 p4 ~' [3 o
LZ有原文吗?或是论文题目。
$ }/ J/ B+ k# j  [, V& YMyoD应该是个transactivator吧。如果是,这个结果是可以预见的。
9 \" {7 p6 Y6 b1 |1 h; B3 d6 [但减少癌症可能性不见得啊?用的还是SKM,又没去除Myc啊。
$ w" P6 M. A& K5 h/ v7 w3 b) T8 J7 p: ]
! Z- N6 C. q2 R! V, `% [  e1 G我的问题是purity为什么会增加呢?恳请有人解答。1 v+ V0 }9 u$ u% Q
; U4 u& [( o1 ]- M" y: d0 z$ M) H
PS:我即将要去UMN读研究生了。很期待
已有 1 人评分威望 包包 收起 理由
细胞海洋 + 5 + 10 欢迎参与讨论

总评分: 威望 + 5  包包 + 10   查看全部评分

Rank: 4

积分
2555 
威望
2555  
包包
600  

优秀会员

藤椅
发表于 2011-7-24 19:07 |只看该作者
回复 托斯卡纳教父 的帖子9 d0 V' p/ W- o$ T- Y' v9 t

. t* x; a+ I2 [恭喜啊,博士还是博士后啊~~8 F. R; l7 Y; t# J
Journal Reference:
( ~) ~% E; ^4 `1 g& J2 ZHiroyuki Hirai, Tetsuya Tani, Nobuko Katoku-Kikyo, Steven Kellner, Peter Karian, Meri Firpo, Nobuaki Kikyo. Radical Acceleration of Nuclear Reprogramming by Chromatin Remodeling With the Transactivation Domain of MyoD. Stem Cells, 2011; DOI: 10.1002/stem.684

Rank: 3Rank: 3

积分
559 
威望
559  
包包
1201  

优秀会员 金话筒

板凳
发表于 2011-7-25 09:12 |只看该作者
干细胞之家微信公众号
回复 zorro 的帖子
, M. E4 x/ r! c! O) i+ S9 U" e" q" |$ M0 b/ ]3 j
PHD啊,我才本科毕业。。。。
6 Q9 ?; ]6 b- w( W
( G# D: o4 Y4 V# V# m: A谢谢了
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2025-6-8 17:00

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.